Hung‐Jen Wang
Papers
2
Total Citations
15
H-Index
2
About
Hung-Jen Wang is a leading urologic oncologist whose research focuses on optimizing surgical and ablative treatments for renal tumors and upper tract urothelial carcinoma (UTUC), particularly in high-incidence regions like Taiwan. His most cited work—a 2021 propensity score-matched study comparing robot-assisted laparoscopic partial nephrectomy (RaPN) with laparoscopic cryoablation for localized renal tumors—demonstrated RaPN’s superior long-term oncologic control while preserving renal function, a critical balance in nephron-sparing surgery. This study, with 11 citations, has informed clinical decision-making for T1a renal masses. Wang also spearheaded a 2024 Taiwan nationwide collaborative study on segmental ureterectomy (SU) for UTUC, providing the first large-scale outcomes analysis from an endemic area. This work, garnering 4 citations, validates SU as a viable option for select mid- and distal ureteral cancers, addressing a gap in regional evidence. His contributions are pivotal in advancing minimally invasive, organ-preserving strategies, with ongoing impact on urologic oncology guidelines. Wang’s research bridges surgical innovation and epidemiological reality, offering tailored solutions for populations with unique disease burdens.
Research Focus
Key Achievements
Top Papers
- 1
- 2